Dr. Hajir Ely Dilmanian, MD

Dr. Dilmanian practices at Kings Physician Services in Yorktown Heights, New York.

Dr. Dilmanian's NPI, 1225252828, was assigned on April 13, 2007. Dr. Dilmanian graduated from SUNY Downstate Health Sciences University in 2001. Dr. Dilmanian holds New York license 230705.

Dr. Dilmanian's primary practice is Kings Physician Services, at 2649 Strang Blvd, Yorktown Heights, NY 10598 in Westchester County. The practice phone is (718) 780-5051.

Dr. Dilmanian's primary practice is Kings Physician Services in Yorktown Heights, New York. Dr. Dilmanian is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Dilmanian to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dilmanian practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Dilmanian's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Dilmanian is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Dilmanian is licensed in New York.

CMS data shows 5,848 Medicare services from Dr. Dilmanian across 30 procedure codes in 2024, for 1,840 Medicare patients. Medicare paid $422,028 for them.

CMS counts 1,840 Medicare patients who saw Dr. Dilmanian in 2024. The largest group is 75 to 84, with 701 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dilmanian's median patient age at 72, with 59% women.

In 2024, Dr. Dilmanian wrote 9,120 Medicare Part D claims for 910 patients. 67% of them were for generic drugs. CMS names the drug for 8,768 of them, across 69 drugs with 11 or more claims each, at $4,877,242 in total drug cost. In 2023, CMS named 7,514 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Dilmanian for performance year 2024, reported as part of a group. Dr. Dilmanian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Dilmanian, published from 2006 to 2007. 2007 was the busiest year, with 3. The most frequent topics are Angioplasty, Balloon, Coronary, Aorta, Thoracic and Aortography. Dr. Dilmanian has published most often in Am J Cardiol. Dr. Dilmanian's most frequent co-authors are Albert J. Deluca, MD, Kumar Siva Kalapatapu, MD and Anthony L. Pucillo, MD.

CMS Open Payments shows 122 general payments to Dr. Dilmanian from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. CVRx, Inc. paid the most, $1,653.

Dmand AI lists 3 awards for Dr. Dilmanian, most recently New York Magazine: Top Doctors in 2014.

Dr. Dilmanian graduated from SUNY Downstate Health Sciences University in 2001. Dr. Dilmanian is a member of ACC.

Dr. Dilmanian is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.